DIS3 and cancer: DIS3 is one of catalytic components of the human RNA processing and degrading exosome it has both endonucleolytic and 3-prime/5-prime exonucleolytic activity [27]; mutations in DIS3 have been observed in several cancer types [28] and in multiple myeloma was observed a shorter survival in patients with DIS3 mutations [29].